Accentia Biopharmaceuticals

Permanently closed
Call
Website

Advertisement

324 S Hyde Park Ave Ste 350
Tampa, FL 33606
Accentia BioPharmaceuticals is an integrated specialty biopharmaceutical company, formed by the Hopkins Capital Group and affiliates to acquire late-stage targeted therapeutics and to use patented delivery technologies to enhance the performance of these therapeutics. The company is focused on the commercialization of 'targeted' therapeutics in patent-protected drug delivery technologies related to respiratory, oncology and critical care. In addition, Accentia partners with physicians, insurers and pharmaceutical manufacturers to guide optimal drug development and patient care, both in the United States and in Europe. The company consists of two wholly owned subsidiaries, and a controlling interest in a third company. Accentia BioPharmaceuticals is publicly traded on NASDAQ under the symbol ABPI and is headquartered in Tampa, Fla.
Own this business?
See a problem?

You might also like

United StatesFloridaTampaAccentia Biopharmaceuticals

Partial Data by Infogroup (c) 2025. All rights reserved.

Partial Data by Foursquare.

Advertisement